NCT01699659View on ClinicalTrials.gov

The Efficacy & Safety of the UAS Immunotherapy Protocol

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Perennial Allergic Rhinitis With Seasonal Variation
Interventions
OTHER

allergen immunotherapy

allergy shots

Trial Locations (1)

78216

UAS, San Antonio

All Listed Sponsors
lead

United Allergy Services

INDUSTRY

NCT01699659 - The Efficacy & Safety of the UAS Immunotherapy Protocol | Biotech Hunter | Biotech Hunter